# Pharma

Owkin staff criticise ‘huge managerial issues’ as French unicorn moves to AI agents
Pro
Investigations
August 7, 2025
Owkin staff criticise ‘huge managerial issues’ as French unicorn moves to AI agents
CEO Thomas Clozel admits the company has not ‘been perfect’ at handling HR issues
Daphné Leprince-Ringuet
How AI is reshaping pharma
Interview
May 19, 2025
How AI is reshaping pharma
The tech could drastically change the industry, but only if it can scale
Sponsored by: Sanofi
Novo Holdings and EIFO invest €48m in Swedish HealthCap's latest fund to strengthen Nordic healthtech
News
April 24, 2025
Novo Holdings and EIFO invest €48m in Swedish HealthCap's latest fund to strengthen Nordic healthtech
HealthCap will establish a local presence in Copenhagen as part of the investment
Mimi Billing
Big pharma is increasing investment into European startups — here’s where capital's being spent in 2024
Pro
Analysis
October 16, 2024
Big pharma is increasing investment into European startups — here’s where capital's being spent in 2024
The majority of the world's most valuable pharma companies have upped dealmaking for European startups this year
Kai Nicol-Schwarz
Eurazeo’s Kurma Partners hits first close of €140m for biotech fund
News
October 3, 2024
Eurazeo’s Kurma Partners hits first close of €140m for biotech fund
The VC is targeting a final close of €250m, which would make the fund its largest to date
Kai Nicol-Schwarz
15 Spanish startups to watch from outside Barcelona and Madrid
Investor survey
April 1, 2024
15 Spanish startups to watch from outside Barcelona and Madrid
The Basque Country, Valencia and Málaga are showing innovation can flourish far from Spain’s two biggest tech hubs
Cristina Gallardo
UK biotech Baseimmune raises £9m to develop ‘mutation-proof’ vaccines
News
February 20, 2024
UK biotech Baseimmune raises £9m to develop ‘mutation-proof’ vaccines
The startup will use the new funds to begin developing more potential vaccine candidates
Kai Nicol-Schwarz
How a “miracle” weight-loss drug created Europe’s most valuable company, and a startup investment machine
Analysis
November 2, 2023
How a “miracle” weight-loss drug created Europe’s most valuable company, and a startup investment machine
With $200m for seed investments annually, the company builder of Novo Holdings is on the prowl for great science
Mimi Billing
Is this the over-the-counter alternative to “miracle drug” Ozempic?
News
October 31, 2023
Is this the over-the-counter alternative to “miracle drug” Ozempic?
Sigrid Therapeutics is raising €4m to bring its blood sugar-lowering products to market
Mimi Billing
Healthtech Manual was selling Ozempic beyond UK government deadline
News
October 27, 2023
Healthtech Manual was selling Ozempic beyond UK government deadline
Sifted was able to reach an order page for ‘miracle drug’ online via Manual more than a week since the October 18 cut-off
Kai Nicol-Schwarz
13 European longevity startups hacking the ageing process
Analysis
October 5, 2023
13 European longevity startups hacking the ageing process
From cell reprogramming to gut health and health clinics — these are the longevity startups investors think you should keep an eye on
Mimi Billing
Causaly raises $60m Series B to give scientists instant access to 'all of biology'
News
July 13, 2023
Causaly raises $60m Series B to give scientists instant access to 'all of biology'
The startup's AI tool can make connections between 35m research papers to answer queries that could take researchers months to find manually
Daphné Leprince-Ringuet
Inside Europe’s largest cannabis manufacturing facility
Places
September 12, 2022
Inside Europe’s largest cannabis manufacturing facility
Somai Pharmaceuticals' 3,800m² facility has been built to satisfy Europe’s growing appetite for the herb
Tim Smith
The Sifted Podcast: Magic mushrooms and startup spiritualism
Podcast
November 26, 2021
The Sifted Podcast: Magic mushrooms and startup spiritualism
Just how big is the psychedelics sector? Click here for nice graphs and The Sifted Podcast episode two.
The Sifted Podcast Team
AI-assisted biotech startup Owkin becomes latest French unicorn
News
November 18, 2021
AI-assisted biotech startup Owkin becomes latest French unicorn
$180m investment from Sanofi shows pharma companies are taking AI tools seriously.
Maija Palmer
Healthtech in 2021 — in 6 charts
Analysis
April 15, 2021
Healthtech in 2021 — in 6 charts
From greater integration of healthtech to its five key subsectors, we've read the latest Dealroom report on healthtech so you don't have to.
Isabella Pojuner
Exscientia raises $100m to build automated drug-hunting platform
News
March 4, 2021
Exscientia raises $100m to build automated drug-hunting platform
The Oxford AI drug discovery company says it can cut down the time of finding new drugs to 6 months with a new automated system.
Maija Palmer
Never mind DeepMind — this London startup is explaining how proteins behave
News
January 8, 2021
Never mind DeepMind — this London startup is explaining how proteins behave
Peptone uses computational molecular physics to help pharma companies understand how protein-based drugs will work.
Maija Palmer
BioNTech: the German biotech behind the coronavirus vaccine
News
November 10, 2020
BioNTech: the German biotech behind the coronavirus vaccine
Founded by migrants to Germany and funded by US and Asian investors: BioNTech is a classic European startup story
Freya Pratty
Why we still won’t be prepared for the next pandemic
Opinion
August 12, 2020
Why we still won’t be prepared for the next pandemic
We need a new funding model for drug discovery.
Dmitry Kuzmin
Four new studies show AI-discovered rheumatoid drug could treat Covid-19
News
July 3, 2020
Four new studies show AI-discovered rheumatoid drug could treat Covid-19
If baricitinib is proven effective it will be a boost for drug discovery firm Benevolent AI.
Maija Palmer
Are psychedelic drugs headed for the mainstream?
News
June 30, 2020
Are psychedelic drugs headed for the mainstream?
Beckley Psytech has raised £3m to turn psychedelic compounds into depression treatments.
Amy Lewin
How AI is finding drugs to treat coronavirus
Analysis
April 15, 2020
How AI is finding drugs to treat coronavirus
Artificial intelligence companies are helping speed up the process of discovering which drugs — existing or new — can be used to treat coronavirus.
Maija Palmer
Coronavirus: Which startups are winning and losing?
Analysis
March 24, 2020
Coronavirus: Which startups are winning and losing?
Europe’s founders on how coronavirus has shaken their plans.
Kitty Knowles

# Pharma

Owkin staff criticise ‘huge managerial issues’ as French unicorn moves to AI agents

How AI is reshaping pharma

Novo Holdings and EIFO invest €48m in Swedish HealthCap's latest fund to strengthen Nordic healthtech

Big pharma is increasing investment into European startups — here’s where capital's being spent in 2024

Eurazeo’s Kurma Partners hits first close of €140m for biotech fund

15 Spanish startups to watch from outside Barcelona and Madrid

UK biotech Baseimmune raises £9m to develop ‘mutation-proof’ vaccines

How a “miracle” weight-loss drug created Europe’s most valuable company, and a startup investment machine

Is this the over-the-counter alternative to “miracle drug” Ozempic?

Healthtech Manual was selling Ozempic beyond UK government deadline

13 European longevity startups hacking the ageing process

Causaly raises $60m Series B to give scientists instant access to 'all of biology'

Inside Europe’s largest cannabis manufacturing facility

The Sifted Podcast: Magic mushrooms and startup spiritualism

AI-assisted biotech startup Owkin becomes latest French unicorn

Healthtech in 2021 — in 6 charts

Exscientia raises $100m to build automated drug-hunting platform

Never mind DeepMind — this London startup is explaining how proteins behave

BioNTech: the German biotech behind the coronavirus vaccine

Why we still won’t be prepared for the next pandemic

Four new studies show AI-discovered rheumatoid drug could treat Covid-19

Are psychedelic drugs headed for the mainstream?

How AI is finding drugs to treat coronavirus

Coronavirus: Which startups are winning and losing?